Pediatric Patients, Surgery for Congenital Heart Disease
Conditions
Keywords
congenital heart disease, rotational thromboelastometry, blood loss, transfusion requirements
Brief summary
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Detailed description
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Interventions
PROCEDUREsurgery for congenital heart disease with cardiopulmonary bypass
surgery for congenital heart disease with cardiopulmonary bypass
Sponsors
Samsung Medical Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 10 Years
Healthy volunteers
No
Inclusion criteria
* pediatric patients (\< 10 years) who underwent surgery for congenital heart disease with cardiopulmonary bypass in 2013 at Samsung Medical Center
Exclusion criteria
* incomplete data about blood loss count or transfusion requirements during seven days after surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative blood loss | during seven days after surgery | daily blood loss measured by chest tube drainage during seven days after surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| postoperative transfusion requirements | during seven days after surgery | postoperative transfusion requirements during seven days after surgery |
Countries
South Korea
Outcome results
None listed